SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : analysts and calls -- B of A

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (10)11/16/2002 4:51:01 PM
From: JFitnich  Read Replies (1) of 33
 
Rick,

I don't think NBIX was covered by BOFA before King. I will check but I believe he started coverage when he joined.

After Silverman left RSCO, King was the only analyst covering companies for a brief period, so he covered a lot of firms. RSCO did bring on Harr who's now at Morgan Stanley, and Tenthoff who went to ThinkEquity. All this of course when Robbie Stephens dissolved.

The other analyst at BOFA (besides Reddoch) jumped to Merril Lynch. (Eric Ende?) My memory is fuzzy as just about every analyst has jumped firms at least once in the past year. I don't think Merril covers NBIX right now FWIW.

JF
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext